Literature DB >> 21296327

Utility of left bundle branch block as a diagnostic criterion for acute myocardial infarction.

Sonia Jain1, Henry T Ting, Malcolm Bell, Christine M Bjerke, Ryan J Lennon, Bernard J Gersh, Charanjit S Rihal, Abhiram Prasad.   

Abstract

The clinical utility of new or "presumably new" left bundle branch block (LBBB) as an electrocardiographic criterion equivalent to ST-segment elevation myocardial infarction in contemporary practice is not well established. The aim of this study was to investigate the hypothesis that new or presumably new LBBB in symptomatic patients frequently leads to an overdiagnosis of acute myocardial infarction (AMI). A retrospective analysis of data from consecutive patients in the Mayo Clinic's ST-segment elevation myocardial infarction network from July 2004 to August 2009 was conducted among 892 patients, 36 (4%) of whom had new LBBB. The frequency, clinical characteristics, serum troponin levels, coronary angiographic findings, and outcomes of patients with new LBBB suspected of having AMI were evaluated. Compared with patients without LBBB (n = 856), those with new LBBB were older (64.5 vs 72.9 years, p < 0.001), had higher Thrombolysis In Myocardial Infarction (TIMI) risk scores (22.7 vs 31.0, p < 0.005), were less likely to undergo primary percutaneous coronary intervention (86% vs 22%, p < 0.001), and had longer door-to-balloon times. Only 14 patients (39%) had final diagnoses of acute coronary syndromes, of which 12 were AMI, while 13 (36%) had cardiac diagnoses other than acute coronary syndrome and 9 (25%) had noncardiac diagnoses. Of the patients with AMI, 5 had occluded culprit arteries, of which 2 involved the left anterior descending coronary artery. A Sgarbossa score ≥ 5 had low sensitivity (14%) but 100% specificity in diagnosing AMI in the presence of new LBBB. In conclusion, new or presumably new LBBB in patients suspected of having AMI identifies a high-risk subgroup, but only a small number have AMI. Two thirds of these patients are discharged from the hospital with alternative diagnoses. The Sgarbossa criteria appear to have limited utility in clinical practice because of their low sensitivity.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2011        PMID: 21296327     DOI: 10.1016/j.amjcard.2010.12.007

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  17 in total

1.  [Diagnostic value of left bundle branch block in patients with acute myocardial infarction. A prospective analysis].

Authors:  Christian Wegmann; Roman Pfister; Steffen Scholz; Anne Markhof; Sebastian Wanke; Kathrin Kuhr; Tanja Rudolph; Stephan Baldus; Hannes Reuter
Journal:  Herz       Date:  2015-07-10       Impact factor: 1.443

2.  Survival in patients without acute ST elevation after cardiac arrest and association with early coronary angiography: a post hoc analysis from the TTM trial.

Authors:  J Dankiewicz; N Nielsen; M Annborn; T Cronberg; D Erlinge; Y Gasche; C Hassager; J Kjaergaard; T Pellis; H Friberg
Journal:  Intensive Care Med       Date:  2015-03-24       Impact factor: 17.440

Review 3.  Cardiological Society of India: Position statement for the management of ST elevation myocardial infarction in India.

Authors:  Santanu Guha; Rishi Sethi; Saumitra Ray; Vinay K Bahl; S Shanmugasundaram; Prafula Kerkar; Sivasubramanian Ramakrishnan; Rakesh Yadav; Gaurav Chaudhary; Aditya Kapoor; Ajay Mahajan; Ajay Kumar Sinha; Ajit Mullasari; Akshyaya Pradhan; Amal Kumar Banerjee; B P Singh; J Balachander; Brian Pinto; C N Manjunath; Chandrashekhar Makhale; Debabrata Roy; Dhiman Kahali; Geevar Zachariah; G S Wander; H C Kalita; H K Chopra; A Jabir; JagMohan Tharakan; Justin Paul; K Venogopal; K B Baksi; Kajal Ganguly; Kewal C Goswami; M Somasundaram; M K Chhetri; M S Hiremath; M S Ravi; Mrinal Kanti Das; N N Khanna; P B Jayagopal; P K Asokan; P K Deb; P P Mohanan; Praveen Chandra; Col R Girish; O Rabindra Nath; Rakesh Gupta; C Raghu; Sameer Dani; Sandeep Bansal; Sanjay Tyagi; Satyanarayan Routray; Satyendra Tewari; Sarat Chandra; Shishu Shankar Mishra; Sibananda Datta; S S Chaterjee; Soumitra Kumar; Soura Mookerjee; Suma M Victor; Sundeep Mishra; Thomas Alexander; Umesh Chandra Samal; Vijay Trehan
Journal:  Indian Heart J       Date:  2017-03-23

Review 4.  Third universal definition of myocardial infarction.

Authors:  Kristian Thygesen; Joseph S Alpert; Allan S Jaffe; Maarten L Simoons; Bernard R Chaitman; Harvey D White
Journal:  Nat Rev Cardiol       Date:  2012-08-25       Impact factor: 32.419

Review 5.  ST-segment elevation: Distinguishing ST elevation myocardial infarction from ST elevation secondary to nonischemic etiologies.

Authors:  Alok Deshpande; Yochai Birnbaum
Journal:  World J Cardiol       Date:  2014-10-26

6.  Letter to the Editor in Response to "Cardiogenic Shock in the Setting of Acute Myocardial Infarction".

Authors:  Michael Carter
Journal:  Methodist Debakey Cardiovasc J       Date:  2020 Jul-Sep

7.  Evolving considerations in the management of patients with left bundle branch block and suspected myocardial infarction.

Authors:  Ian J Neeland; Michael C Kontos; James A de Lemos
Journal:  J Am Coll Cardiol       Date:  2012-07-10       Impact factor: 24.094

8.  Left bundle branch block and suspected myocardial infarction: does chronicity of the branch block matter?

Authors:  Vasileios Liakopoulos; Thomas Kellerth; Kjeld Christensen
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

9.  Diagnosis and outcome in a prehospital cohort of patients with bundle branch block and suspected acute myocardial infarction.

Authors:  Jacob Thorsted Sørensen; Carsten Stengaard; Christina Ankjær Sørensen; Kristian Thygesen; Hans Erik Bøtker; Leif Thuesen; Christian Juhl Terkelsen
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-06

10.  Acute Myocardial Infarction due to Coronary Artery Embolism in a Patient with a Tissue Aortic Valve Replacement.

Authors:  Joel T Levis; Geoffrey Schultz; Philip C Lee
Journal:  Perm J       Date:  2011
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.